Literature DB >> 9619643

Molecular characterisation of Duchenne muscular dystrophy and phenotypic correlation.

A Mital1, D Kumari, M Gupta, S Goyle.   

Abstract

Dystrophin gene was analysed in 32 unrelated DMD families (46 subjects: 32 index cases and 14 sibs) for the presence of deletions by mPCR for 27 exons and cDNA probes for the entire gene. Deletions were identified in 32 patients (25 index cases and seven sibs) from 25 families. The concordance between the clinical phenotype and 'reading frame' hypothesis was observed in 24 (75%) cases. Of these, nine patients were wheelchair bound between 8-12 years of age, nine (age range 5-10 years) showed progressive difficulty in walking and six (age range 1.6-4 years) had onset of muscle weakness. One patient (CH), who was wheelchair bound at 12 years, the effect of mutation on the ORF could not be ascertained due to the presence of a junction fragment. Seven patients had inframe deletions of which four were wheelchair bound by the age of 13 years, and three (age range 5-7 years) although, ambulatory had difficulty in walking. There were eight patients who showed no deletion, of which four became wheelchair bound by the age of 12 years, four, though still ambulatory, were unable to run and tired easily. Correlation between phenotype and genotype of these DMD patients demonstrates that genetic studies of lymphocyte DNA may not always reflect the situation in the tissue involved in dystrophin, i.e. muscle. We describe a common dystrophin gene polymorphism in the Indian population with cDNA 11-14 that alters the Hind III restriction sites. Novel RFLPs were observed in 26 patients and their family members. Whether this is a polymorphism or, related to the diseased phenotype needs confirmation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619643     DOI: 10.1016/s0022-510x(98)00051-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

Review 2.  Current concepts in dystrophinopathies.

Authors:  Venkataraman Viswanathan
Journal:  Indian J Pediatr       Date:  2014-11-23       Impact factor: 1.967

3.  Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy.

Authors:  Gholamreza Zamani; Sareh Hosseinpour; Mahmoud Reza Ashrafi; Mahmoud Mohammadi; Reza Shervin Badv; Ali Reza Tavasoli; Masood Ghahvechi Akbari; Ali Hosseini Bereshneh; Reza Azizi Malamiri; Morteza Heidari
Journal:  BMC Neurol       Date:  2022-05-02       Impact factor: 2.903

4.  Novel Exon-Skipping Therapeutic Approach for the DMD Gene Based on Asymptomatic Deletions of Exon 49.

Authors:  Mario Abaji; Svetlana Gorokhova; Nathalie Da Silva; Tiffany Busa; Maude Grelet; Chantal Missirian; Sabine Sigaudy; Nicole Philip; France Leturcq; Nicolas Lévy; Martin Krahn; Marc Bartoli
Journal:  Genes (Basel)       Date:  2022-07-19       Impact factor: 4.141

5.  Incidental copy-number variants identified by routine genome testing in a clinical population.

Authors:  Philip M Boone; Zachry T Soens; Ian M Campbell; Pawel Stankiewicz; Sau Wai Cheung; Ankita Patel; Arthur L Beaudet; Sharon E Plon; Chad A Shaw; Amy L McGuire; James R Lupski
Journal:  Genet Med       Date:  2012-08-09       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.